OmniAb

Yahoo Finance • 5 months ago

Veraxa and OmniAb to develop bispecific ADC tumour programme

Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) programme aimed at solid tumours. The partnership unites OmniAb's transgenic antibody discovery solutions with Ve... Full story